Edwards Lifesciences

EW · NYSE

$88.29+$1.07 (+1.23%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $87.22

News sentiment

Tone of recent coverage

Social media sentiment, last 30 days

Average tone of posts mentioning EW, from −1 (all negative) to +1 (all positive). Latest day: −0.33 across 15 mentions.

Latest news

NewsOct 16, 11:13 AM ETVandana Singh
FDA Flags High-Risk Heart Device Recall At Edwards Lifesciences After Patient Death
Press releaseOct 7, 6:00 AM ETBusiness Wire
Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026
Press releaseOct 5, 6:00 AM ETBusiness Wire
Edwards Lifesciences to Host Investor Event in Conjunction With TCT
NewsOct 2, 10:46 AM ETVandana Singh
Edwards Lifesciences Secures FDA Approval for First Expandable Pediatric Heart Valve
NewsOct 2, 4:16 AM ETAvi Kapoor
Nike, Synaptics And 3 Stocks To Watch Heading Into Friday
Press releaseOct 1, 4:26 PM ETBusiness Wire
Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients
Press releaseSep 10, 5:49 PM ETBusiness Wire
Edwards Lifesciences Comments on TAVR National Coverage Decision
Press releaseSep 7, 3:32 PM ETPRNewswire
Did Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders?
Press releaseSep 2, 4:15 PM ETBusiness Wire
Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit
NewsAug 14, 1:35 PM ET
9 Health Care Stocks Whale Activity In Today’s Session
NewsJul 24, 11:48 AM ETVandana Singh
Edwards Earnings Add Fuel To Bullish MedTech Thesis, Analyst Says
NewsJul 24, 9:02 AM ETRishabh Mishra
Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Gain as Oil Prices Decline—Intel, Edwards Lifesciences, SAP in Focus (UPDATED)
NewsJul 24, 2:16 AM ETAvi Kapoor
American Express, Deckers Outdoor And 3 Stocks To Watch Heading Into Friday
NewsJul 23, 4:15 PM ET
Edwards Lifesciences Q2 Adj. EPS $0.78 Beats $0.74 Estimate, Sales $1.741B Beat $1.700B Estimate
Press releaseJul 23, 4:15 PM ETBusiness Wire
Edwards Lifesciences Reports Second Quarter Results
NewsJul 23, 7:11 AM ET
Earnings Scheduled For July 23, 2026
Press releaseJul 16, 7:05 AM ETBusiness Wire
Edwards Lifesciences to Host Earnings Conference Call on July 23, 2026
Press releaseJul 3, 12:34 PM ETPRNewswire
Did Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders?
Press releaseJun 26, 10:15 AM ETBusiness Wire
Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves
NewsJun 16, 1:52 PM ETVandana Singh
Edwards Lifesciences Stands Out As US Agency Eyes Broader Access For Heart Valve Device
Press releaseMay 4, 4:45 PM ETBusiness Wire
Edwards Lifesciences Announces Appointment of CFO
Press releaseMay 2, 11:50 AM ETBusiness Wire
Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences' Resilia Tissue
Press releaseApr 28, 7:05 AM ETBusiness Wire
Edwards Lifesciences to Present at the BofA Securities 2026 Health Care Conference
NewsApr 24, 12:50 PM ETVandana Singh
Edwards Lifesciences Stock Surges On Heart Valve Devices Growth
NewsApr 23, 6:05 PM ET
Transcript: Edwards Lifesciences Q1 2026 Earnings Conference Call
Press releaseApr 23, 4:15 PM ETBusiness Wire
Edwards Lifesciences Reports First Quarter Results
Press releaseApr 16, 9:00 AM ETGlobe Newswire
The Quiet Shift Replacing Million-Dollar Heart Scanners With Software
Press releaseApr 16, 7:05 AM ETBusiness Wire
Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026
Press releaseMar 30, 10:00 AM ETBusiness Wire
Two Year Data on Edwards Lifesciences' EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits
Press releaseFeb 26, 9:15 AM ETBusiness Wire
Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose
Press releaseFeb 19, 7:05 AM ETBusiness Wire
Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences
Press releaseFeb 13, 7:05 AM ETBusiness Wire
Edwards Lifesciences to Present at Citi's 2026 Unplugged Medtech and Life Sciences Access Day
Press releaseFeb 10, 4:15 PM ETBusiness Wire
Edwards Lifesciences Reports Fourth Quarter Results
NewsFeb 9, 11:01 AM ET
Insights Ahead: Edwards Lifesciences's Quarterly Earnings
Press releaseJan 16, 11:40 AM ETGlobe Newswire
AI Diagnostics: The End of the High-Cost Imaging Era
NewsJan 15, 8:42 AM ETAkanksha Bakshi
Boston Scientific Acquires Penumbra In $14.5 Billion Bet To Dominate Thrombectomy
Press releaseDec 4, 9:00 AM ETBusiness Wire
Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference
Press releaseAug 25, 4:33 AM ETPRNewswire
Pulnovo Medical Names Dr. Francis Duhay as Global Chief Medical Officer
NewsAug 8, 11:03 AM ETVandana Singh
FTC Sounds Alarm On Edwards' Attempt To Corner Heart Device Market
NewsFeb 26, 8:45 AM ET
A Look Into Edwards Lifesciences Inc's Price Over Earnings
NewsJul 11, 4:15 PM ET
P/E Ratio Insights for Edwards Lifesciences

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

News sentiment

Social media sentiment, last 30 days

Latest news

FDA Flags High-Risk Heart Device Recall At Edwards Lifesciences After Patient Death

Edwards Lifesciences to Host Earnings Conference Call on November 4, 2026

Edwards Lifesciences to Host Investor Event in Conjunction With TCT

Edwards Lifesciences Secures FDA Approval for First Expandable Pediatric Heart Valve

Nike, Synaptics And 3 Stocks To Watch Heading Into Friday

Edwards Lifesciences Receives FDA Approval for AUTUS Valve, the First Surgical Pulmonary Valve for Pediatric Patients

Edwards Lifesciences Comments on TAVR National Coverage Decision

Did Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders?

Edwards Lifesciences to Present at the Deutsche Bank Healthcare Summit

9 Health Care Stocks Whale Activity In Today’s Session

Edwards Earnings Add Fuel To Bullish MedTech Thesis, Analyst Says

Stock Market Today: S&P 500, Dow Jones, Nasdaq 100 Futures Gain as Oil Prices Decline—Intel, Edwards Lifesciences, SAP in Focus (UPDATED)

American Express, Deckers Outdoor And 3 Stocks To Watch Heading Into Friday

Edwards Lifesciences Q2 Adj. EPS $0.78 Beats $0.74 Estimate, Sales $1.741B Beat $1.700B Estimate

Edwards Lifesciences Reports Second Quarter Results

Earnings Scheduled For July 23, 2026

Edwards Lifesciences to Host Earnings Conference Call on July 23, 2026

Did Edwards Lifesciences Corporation Insiders Breach their Fiduciary Duties to Shareholders?

Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves

Edwards Lifesciences Stands Out As US Agency Eyes Broader Access For Heart Valve Device

Edwards Lifesciences Announces Appointment of CFO

Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences' Resilia Tissue

Edwards Lifesciences to Present at the BofA Securities 2026 Health Care Conference

Edwards Lifesciences Stock Surges On Heart Valve Devices Growth

Transcript: Edwards Lifesciences Q1 2026 Earnings Conference Call

Edwards Lifesciences Reports First Quarter Results

The Quiet Shift Replacing Million-Dollar Heart Scanners With Software

Edwards Lifesciences to Host Earnings Conference Call on April 23, 2026

Two Year Data on Edwards Lifesciences' EVOQUE System Continue to Demonstrate Significant and Sustained Patient Benefits

Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose

Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences

Edwards Lifesciences to Present at Citi's 2026 Unplugged Medtech and Life Sciences Access Day

Edwards Lifesciences Reports Fourth Quarter Results

Insights Ahead: Edwards Lifesciences's Quarterly Earnings

AI Diagnostics: The End of the High-Cost Imaging Era

Boston Scientific Acquires Penumbra In $14.5 Billion Bet To Dominate Thrombectomy

Edwards Lifesciences Reaffirms Strategy for Sustainable, Differentiated Growth at Annual Investor Conference

Pulnovo Medical Names Dr. Francis Duhay as Global Chief Medical Officer

FTC Sounds Alarm On Edwards' Attempt To Corner Heart Device Market

A Look Into Edwards Lifesciences Inc's Price Over Earnings

P/E Ratio Insights for Edwards Lifesciences